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Abstract
Background: Protein degradation by the ubiquitin system plays a crucial role in numerous cellular
signaling pathways. Deubiquitination, a reversal of ubiquitination, has been recognized as an
important regulatory step in the ubiquitin-dependent degradation pathway.
Results:  While identifying putative ubiquitin specific protease (USP) enzymes that contain a
conserved Asp (I) domain in humans, 4 USP17 subfamily members, highly homologous to DUB-3,
have been found (USP17K, USP17L, USP17M, and USP17N), from human chorionic villi. Expression
analysis showed that USP17 transcripts are highly expressed in the heart, liver, and pancreas and
are expressed moderately in various human cancerous cell lines. Amino acid sequence analysis
revealed that they contain the highly conserved Cys, His, and Asp domains which are responsible
for the deubiquitinating activity. Biochemical enzyme assays indicated that they have
deubiquitinating activity. Interestingly, the sequence analysis showed that these proteins, with
exception of USP17N, contain the putative hyaluronan/RNA binding motifs, and cetylpyridinium
chloride (CPC)-precipitation analysis confirmed the association between these proteins and
intracellular hyaluronan and RNA.
Conclusion: Here, we report that the overexpression of these proteins, with exception of
USP17N, leads to apoptosis, suggesting that the hyaluronan and RNA binding motifs in these
enzymes play an important role in regulating signal transduction involved in cell death.
Background
The post-translational modification by ubiquitin (Ub)
plays an essential role for numerous cellular functions
such as protein degradation, cell cycle control, transcrip-
tional regulation, immune response, apoptosis, oncogen-
esis, pre-implantation, and intracellular signaling
pathways [1-6]. Conjugation of ubiquitin to a target pro-
tein is achieved by the sequential enzymatic actions via
ubiquitin-activating enzymes (E1), ubiquitin-conjugating
enzymes (E2), and ubiquitin ligases (E3). A novel ubiqui-
tination factor (E4) required for efficient multiubiquitina-
tion has been identified in yeast [7]. Proteins modified
with a polyubiquitin chain are then unfolded and
degraded by the 26S proteasome [1,4,5]. Deubiquitina-
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tion, a removal of ubiquitin from ubiquitin-conjugated
protein substrates, is mediated by a number of deubiqui-
tinating enzymes. Most deubiquitinating (DUB) enzymes
are cysteine proteases and consist of at least five families,
the ubiquitin C-terminal hydrolases (UCH), the ubiquitin
specific processing proteases (USP), Jab1/Pab1/MPN-
domain-containing metallo-enzymes (JAMM), Otu-
domain ubiquitin aldehyde-binding proteins (OTU), and
Ataxin-3/Josephin [8-10]. The USP family members vary
in size and structural complexity, but all contain 6 charac-
teristic conserved homology domains [5]. The UCH fam-
ily members are relatively small molecules, which
hydrolyze C-terminal amides and esters of ubiquitin [5].
The JAMM isopeptidases are known to deneddylate cullin
(the CSN-5 subunit of the COP9/signalosome) and to
release ubiquitin chains from proteins targeted for degra-
dation (the RPN11 subunit of the proteasome) [11]. The
members of OTU family have been reported as highly spe-
cific Ub isopeptidases, but they have no sequence homol-
ogy to known DUBs [12]. Lastly, Ataxin-3 has a domain
called the Josephin domain, cleaves ubiquitin-AMC, and
binds to the DUB inhibitor ubiquitin aldehyde [8].
Hyaluronan is a kind of glycosaminoglycan, which is
involved in the regulation of cell division [13], angiogen-
esis [14,15], and cell motility [16]. Hyaluronan exists in
extracellular and pericellular matrices and interacts with
various kinds of proteins [17]. Recent reports showed the
existence of a few intracellular hyaluronan binding pro-
teins (IHABPs) and one of them, receptor form hyaluro-
nan-mediated motility (RHAMM) binds intracellular
hyaluronan and plays multiple roles including cell cycle
arrest [18] and spindle pole stability [19].
USP17 subfamily members have been previously identi-
fied [20] and one of them, DUB-3, has shown that the
constitutive expression of DUB-3 blocks proliferation and
can lead to apoptosis [21]. In this study, we have identi-
fied four novel members of USP17  subfamily which
encode a deubiquitinating enzyme, from human chori-
onic villi tissues. Our study demonstrates for the first time
that USP17 subfamily members of the DUB enzyme regu-
late apoptosis and cell death of cancerous cells and con-
tain putative hyaluronan and RNA binding domains.
Results
Cloning of USP17 subfamily members in human chorionic 
villi and embryonic carcinoma cell lines
To identify putative deubiquitinating enzymes that con-
tain a conserved Asp (I) domain in humans, the GenBank
database was accessed and searched using the BLAST algo-
rithm at the NCBI, as described previously [22]. In this
study, we obtained multiple cDNAs including DUB-3 [21]
and USP17 [23] from human chorionic villi tissues and
various cancer cell lines by RT-PCR. We performed RT-
PCR, sequenced PCR products three times independently
in order to exclude the possibility of PCR errors, and clas-
sified the genes as USP17 subfamily members (USP17K,
USP17L, USP17M, and USP17N) due to the high homol-
ogy to known sequences [20,21]. To characterize the
genetic properties of human USP17 genes, the complete
nucleotide sequences of USP17K, USP17L, USP17M, and
USP17N  [GenBank: AF544011, AF544012, AY188990,
and AY533200, respectively] were analyzed. Nucleotide
and deduced amino acid sequences were analyzed with
the SeqEd V1.0.3 program and Clustal method of the
MegAlign program, a multiple alignment program of the
DNASTAR package. The full-length cDNAs for USP17K,
USP17L and USP17M consist of 1593 nucleotides in open
reading frame and the deduced amino acid sequence of
530 amino acids with a calculated molecular mass of 58
kDa (Additional File 1). The full-length cDNA for
USP17N  consists of 1197 nucleotides in open reading
frame and the deduced amino acid sequence of 398
amino acids with a calculated molecular weight of 44.5
kDa (Additional File 1). The conserved Cys, His and Asp
domains, which are thought to form the active site of the
deubiquitinating enzymes, are also found in the USP17K,
USP17L, USP17M and USP17N (Fig. 1); these conserved
domains have been previously shown in other deubiqui-
tinating enzymes including USP36 [24], DUB-1 [25], and
DUB-2 [26]. Sequence analysis for amino acids of novel
USP17 subfamily members indicates that USP17K,
USP17L and USP17M have high degree of homology
(>95%), and USP17N is identical with USP17C when
compared with each other and USP17 family members
(Table 1). Phylogenetic analysis for nucleotide sequences
and deduced amino acid sequences of novel genes
revealed that all novel genes were grouped into the USP17
subfamily (Fig. 2) and they were characterized in this
report.
Examination of the deduced amino acid sequence of these
enzymes by Pfam [27] revealed that novel subfamily
members of USP17 contain the putative conserved
hyaluronan binding motifs (Fig. 3) -(R/K)X7(R/K)- [28].
These putative motifs are located between amino acid res-
idues Arg 401 to Lys 410, and Lys 445 to Lys 453 (Fig. 3).
In addition, "RGG" amino acid sequences predicted for
the novel RNA binding motif are found at the C-terminus.
Interestingly, USP17N lacks of these binding motifs (Fig.
3), suggesting the unique functional roles for these motifs.
Even though it has been suggested that human USP17
subfamily members are homologous to murine DUB sub-
family members due to the fact that they are cytokine-
inducible and regulate cell growth and survival [20],
hyaluronan and RNA binding motifs are not found in
members of murine DUB subfamily (data not shown).BMC Genomics 2006, 7:292 http://www.biomedcentral.com/1471-2164/7/292
Page 3 of 15
(page number not for citation purposes)
Expression of transcripts for novel USP17 subfamily 
members in human tissues and cancerous cells
To investigate the expression pattern of transcripts for
novel USP17 subfamily members in human tissues and
cancerous cells, Northern blot and RT-PCR analyses were
performed. As shown in Figure 4A, Northern blot analysis
revealed that transcripts for novel USP17 subfamily mem-
bers were expressed in the heart, liver, and pancreas at a
high level. Interestingly, we obtained multiple bands hav-
ing different sizes (1.7 kb, 1.6 kb, 1.3 kb, 1 kb) using a 5'
500 bp probe of USP17L  (Probe: N-500). We also
detected 1.6 kb and 1.7 kb major bands of USP17 sub-
family members using a probe designed for a 3' 1 kb
probe of USP17L (Probe: C-1000) (Fig. 4A). It is possible
that other minor mRNA transcripts around 1.3 kb and 1
kb, which have not been detected with DUB-3 probe [21],
may be derived from alternative splicing, promoter usage,
or poly (A+) usage. The presence of a few different sizes of
transcript indicates that novel genes belong to the USP17
subfamily and that there are at least several members of
this family present. In addition to various human tissues,
RT-PCR analysis showed that the expression of transcripts
for novel USP17 subfamily members was detected in var-
ious human cancer cell lines including HeLa, HEC-1A,
NCCIT, and fibrosarcoma cells (Fig. 4B).
Novel USP17 subfamily members as a deubiquitinating 
enzyme
To determine whether novel USP17 subfamily proteins
have ubiquitin specific protease enzymatic activity, deu-
Conserved domains of USP17 subfamily members were compared with other deubiquitinating enzymes including human  USP36, mouse DUB-1, and DUB-2 Figure 1
Conserved domains of USP17 subfamily members were compared with other deubiquitinating enzymes including human 
USP36, mouse DUB-1, and DUB-2. These domains are critical for the function of deubiquitinating enzymes.
81 GLQNMGNTCYVNASLQCLT  99  USP17s
123 GLHNLGNTCFLNATIQCLT 141  USP36
52 GLQNTGNSCYLNAALQCLT  70  DUB-1
52 GLQNTGNSCYLNAALQCLT  70  DUB-2
153  FHRGKQEDAHEFLMFT   168  USP17s
201  FRFGNQEDAHEFLRYT   216  USP36
126  FHKHQQEDAHEFLMFT   141  DUB-1
126  FHKHQQEDAHEFLMFT   141  DUB-2
320 YAVLVHAGWSCHNGHYF  336  USP17s
368  YAVLVHSGYSCHAGHYY  384  USP36
293  YAVLVHDGATSHSGHYF  329  DUB-1
293  YAVLVHEGATCHSGHYF  329  DUB-2 
Cysteine domain
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Histidine domain
343  EGQWYKMDDAEVTASSI  359  USP17s
391  NGQWYQMNDSLVHSSNV  407  USP36
316  HGKWYKMDDTKVTRCDV  332  DUB-1
316  HGAWYKMDDTKVTSCDV  332  DUB-2
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biquitinating enzyme assays were performed. For in vitro
enzyme assay, novel USP17 subfamily members were
expressed as a GST fusion protein. As shown by immuno-
blotting analysis (Fig. 5), four GST fusion proteins dem-
onstrated a strong efficient cleavage of Ub-Met-β-gal (Fig.
5; lanes 2, 4, 6, and 8). We generated the Cys conserved
domain mutant for each of novel USP17 subfamily pro-
teins (C89S) using a site-directed mutagenesis method. As
expected, cells with the empty vector alone (Fig. 5, lane 1)
and mutants (Fig. 5; lanes 3, 5, 7 and 9) failed to cleave
Ub-Met-β-gal.
For  in vivo deubiquitinating enzyme assay, HA-tagged
pMT123-ubiquitin was transiently expressed in human
endometrial carcinoma cells (HEC-1A) with or without
pcDNA3-myc-USP17L  and pcDNA3-myc-USP17L
(C89S). Then, we analyzed deubiquitinating enzyme
activity by immunoblotting using a monoclonal anti-HA
antibody. The expression bands of polyubiquitinated pro-
teins were nearly invisible in cells expressing pcDNA3-
myc-USP17L (Fig. 6; lane 4), but not in cells expressing
pcDNA3-myc-USP17L (C89S) (Fig. 6; lane 5). The molec-
ular weight for a mutant form of USP17L (C89S) is bigger
than wild type USP17L, suggesting that there may be a
conformational change due to the amino acid substitu-
tion. In addition, other USP17 subfamily members
showed the deubiquitinating enzyme activity in vivo (data
not shown). Taken together, we concluded that novel
USP17 subfamily proteins have deubiquitinating enzyme
activity.
Hyaluronan/RNA-binding properties of USP17 subfamily 
proteins
Since it is not known whether hyaluronan-binding sites
within USP17 subfamily proteins are indeed functional,
we further examined whether USP17 subfamily proteins
actually binds hyaluronan. The cetylpyridinium chloride
(CPC)-precipitation assay has been used for investigating
binding affinity [29] and the assay in our study demon-
strated that USP17 subfamily proteins interact with
hyaluronan based on the comparison of binding intensity
between endogenous and exogenous hyaluronans (Fig.
7A, lanes 4 and 5). However, USP17N did not interact
with hyaluronan (Fig. 7A, lane 5), indicating that the C-
terminal domain of USP17 subfamily proteins is required
for binding with hyaluronan.
Since it has been reported that the HABP4_PAI-RBP1
domain, which is involved in mRNA stability [30], inter-
acts with both hyaluronan and RNA [17], we additionally
investigated the activity of USP17 subfamily proteins for
binding with RNA. We performed the CPC-precipitation
Table 1: Percent amino acid identity among USP17 subfamily and DUB subfamily members.
USP17A USP17B USP17C USP17D USP17F USP17G USP17H USP17I USP17J USP17 DUB-3 USP17K USP17L USP17M USP17N
100.0 94.0 98.5 99.5 93.6 94.3 100.0 100.0 100.0 97.0 99.3 99.2 98.3 99.2 98.5 USP17A
100.0 94.0 94.5 99.2 93.4 94.0 94.0 94.0 96.2 94.7 94.3 93.4 94.0 94.0 USP17B
100.0 99.2 93.5 40.4 98.5 98.5 98.5 95.7 99.0 98.7 99.0 98.2 100.0 USP17C
100.0 94.0 40.8 99.5 99.5 99.5 96.2 99.5 99.2 98.5 98.7 99.2 USP17D
100.0 92.5 93.6 93.6 93.6 95.8 94.2 94.0 93.0 94.0 93.5 USP17F
100.0 94.3 94.3 94.3 95.2 47.4 95.2 93.0 93.9 40.4 USP17G
100.0 100.0 100.0 97.0 99.3 99.2 98.3 99.2 98.5 USP17H
100.0 100.0 97.0 99.3 99.2 98.3 99.2 98.5 USP17I
100.0 97.0 99.3 99.2 98.3 99.2 98.5 USP17J
100.0 96.6 97.4 96.4 97.0 95.7 USP17
100.0 99.5 98.8 99.0 99.0 DUB-3
100.0 98.7 99.2 98.7 USP17K
100.0 98.3 99.0 USP17L
100.0 98.2 USP17M
100.0 USP17N
Phylogenetic tree assignments of USP17 subfamily members Figure 2
Phylogenetic tree assignments of USP17 subfamily members. 
Sequence names and GenBank accession numbers are as fol-
lows: USP17, AY509884; DUB-3, BC100991; USP17A, 
XM_377832; USP17B, XM_373239; USP17C, NM_212553; 
USP17D, XM_373021; USP17F, XM_376741; USP17G, 
XM_376754; USP17H, XM_377837; USP17I, XM_377835; 
USP17J, XM_377834; USP17K, AF544011; USP17L, 
AF544012; USP17M, AY188990, USP17N, AY533200. Novel 
members of USP17 subfamily are underlined. USP17E 
sequence identified previously [20] could not be located with 
the reported GenBank accession number (NM_001324).
USP17I
USP17J
USP17H
USP17A
USP17M
USP17C
USP17N
USP17L
USP17D
DUB-3
USP17K
USP17
USP17B
USP17F
USP17GBMC Genomics 2006, 7:292 http://www.biomedcentral.com/1471-2164/7/292
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assay and found that USP17 subfamily proteins also bind
to RNA in a dose-dependent manner (Figs. 7A and 7B).
Interestingly, USP17N did not interact with RNA as
shown with hyaluronan (Fig. 7A, lane 6), indicating that
the C-terminal domain of USP17 subfamily proteins is
also required for binding with RNA.
Localization study of USP17L
In order to investigate the intracellular localization of
USP17 subfamily proteins, the GFP-tagged USP17L or
RFP-tagged USP17N, or both were transfected into HeLa
cells. Intriguingly, USP17L proteins are found in the
nucleus and are concentrated at the nucleoli (Figs. 8E and
8H) similar to intracellular hyaluronan [31]. However,
USP17N proteins are localized both in the nucleus and
cytoplasm (Figs. 8F and 8I). A merged format shows that
USP17L and USP17N are localized in different regions
(Figs. 8G and 8J). After 48 hours of transfection, cells
expressing GFP-tagged USP17L showed the onset of irreg-
ular nuclear division and irregular morphology of overall
cell shape compared with controls (data not shown). In
contrast, cells expressing RFP-tagged USP17N  did not
show any sign of apoptosis, suggesting that hyaluronan
binding ability and the localization of USP17 subfamily
proteins may be critical for regulating apoptosis leading to
cell death.
Regulation of cell viability
Since it has been suggested that intracellular hyaluronan
binding proteins are involved in tumor formation
[32,33], we next investigated whether the USP17 sub-
family proteins are involved in the regulation of cell via-
bility and cell cycle for cancer cells. In order to investigate
the cellular roles of USP17 subfamily proteins, myc-
tagged USP17L was transfected into HEC-1A and HeLa
cells to establish stable cell lines. However, we observed
transfected cells undergoing apoptosis (Fig. 9) and
approximately 3 weeks later, all cells died. However, the
transfection of either USP17L (C89S) or USP17N into the
same cell lines did not result in any sign of apoptosis (Fig.
9). This indicates that USP17 subfamily proteins contain-
ing hyaluronan binding motifs and their substrate(s) may
regulate cell viability. Based on the observation of cell
death for USP17L-transfected cells, we performed quanti-
tative real-time PCR to compare fold change for the
expression of caspase 3 as an indicator of apoptosis. The
expression of caspase 3 showed more than two fold
increase in USP17L-transfected cells compared with con-
trols (Fig. 10). However, the expression of caspase 3 in
USP17L  (C89S)-transfected cells and in USP17N-trans-
fected cells was similar to one in controls (Fig. 10). All
reactions were performed triplicate.
In order to confirm the apoptosis induced by USP17 sub-
family proteins, USP17L was stably expressed by the Tet-
on system. The morphology of cells undergoing apoptosis
was similar to that of ones transfected with pcDNA3-myc-
USP17L (data not shown). Therefore, we harvested the
USP17L-expressing cells at 1 week intervals for 3 weeks
and analyzed through FACS analysis. The rate of apopto-
sis for cells expressing either USP17L or USP17L (CS) was
analyzed by double-staining with annexin V and PI (Fig.
Schematic diagram of structural features for USP17 subfamily members Figure 3
Schematic diagram of structural features for USP17 subfamily members. The domains required for deubiquitinating activity 
(Cys, Asp (I) His, Asp/Asn (II)) are located at the 5' end and middle of enzymes. Two potential hyaluronan binding motifs R/
K(X7)R/K are located at amino acids 401 to 410, and 445 to 453.
Cys         Asp(I)               His    Asp/Asn(II)      
Hyaluronan/RNA
binding motifs
1
1 398
Cys         Asp(I)               His    Asp/Asn(II)      
USP17N
USP17K-M
530
N
N
C
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11). The cell stages of apoptosis were differentiated
depending on the location in the quadrant (annexin V +,
PI -; early stage) and (annexin V +, PI +; late stage) [34].
The USP17L-expressing cells by the Tet-on system under-
going the early stage apoptosis showed about 2.5 fold
increase compared with control HeLa cells and those
undergoing late stage apoptosis showed about 1.5 fold
increase (Fig. 11). However, the significant change was
not observed in cells expressing USP17L (CS) or USP17N
(Fig. 11). This experiment was performed triplicate.
Discussion
The ubiquitin-mediated protein degradation pathway has
diverse functions involved in the regulation of protein
activity, indicating the importance of the system in
eukaryotic cells. Specific modulation by diverse deubiqui-
Northern blot analysis for USP17 subfamily members in human tissues and RT-PCR analysis in human tumor cell lines Figure 4
Northern blot analysis for USP17 subfamily members in human tissues and RT-PCR analysis in human tumor cell lines. (A) 
Northern blot analysis was carried out to investigate the expression level of USP17 subfamily members in human tissues. The 
5' 500 bp- and 3' 1 kb-probes of USP17L were used. The multiple transcript sizes of USP17 mRNA including 1.6 kb were 
detected. The same blot was probed with the human β-actin as a loading control. (B) Global expression of USP17 subfamily 
members in various cancer cell lines.
2.4
1.35
˟ ˟ ˟ ˟-actin
USP17s
2.4
1.35
USP17s
Probe: 5’ 500
Probe: 3’ 1000
heart
brain
lung
placenta
liver
pancreas
muscle
kidney
USP17s
Chorionic villi (positive control)
HEC-1A
HeLa
Fibrosarcoma
Embryonic Carcinoma (NCCIT)
A
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tinating enzyme is a key process controlling many pro-
teins associated with the ubiquitin-proteasome system. In
this study, we isolated four novel members of USP17 sub-
family and showed through sequence analysis that they
have high degree of homology when compared with each
other and USP17 (Additional File 1). Phylogenetic analy-
sis for nucleotide sequences and deduced amino acid
sequences of USP17 subfamily members revealed that all
novel genes were grouped into the USP17 subfamily (Fig.
1). It has been recently reported that there are multiple
homologous genomic sequences of USP17 subfamily, and
one of them, DUB-3, encodes a cytokine-inducible deu-
biquitinating enzyme [21]. This is similar to murine DUB
subfamily members including DUB-1, DUB-2, DUB-2A,
and  DUB-1A  [1,9,25,26]. However, whether they have
distinct functions or polymorphisms remains to be seen.
Since USP17 transcripts were expressed in various cancer
cell lines and it has been suggested that intracellular
hyaluronan binding proteins, which USP17 subfamily
members belong to, are involved in tumor formation
[33], we investigated whether USP17 subfamily proteins
are involved in cell growth and proliferation. Interest-
ingly, we observed that cancer cells (HeLa and HEC-1A)
overexpressing USP17 subfamily proteins except USP17N
appeared morphologically abnormal. In addition, FACS
analysis showed that double-staining of USP17L-express-
ing, but not USP17N-expressing cells with annexin V and
PI revealed increased apoptosis (Figs. 11A and 11B).
These results suggest that USP17 subfamily proteins con-
taining hyaluronan and RNA binding motifs are involved
in signaling pathway of death for tumorigenic cells.
Besides the fact that the overexpression of USP17 sub-
family proteins induces apoptosis in cancer cells, the abil-
ity to bind with hyaluronan is another important point
used to elucidate the cellular functions of USP17 sub-
family proteins. Hyaluronan is one of glycosaminogly-
cans and is believed to play various roles both in
extracellular and pericellular matrices [32,35]. Since
enriched hyaluronan is found in various tumor tissues
[32,33], it was thought to be important for cancer. Several
evidences have been proposed to prove the connection
between hyaluronan and tumor growth. Therefore,
hyaluronan is used as a marker for various cancers these
days [32,33]. In addition, hyaluronan has been suggested
that it is involved in the fundamental regulation of cell
cycle, because hyaluronan is enriched in the nucleus dur-
Deubiquitinating enzyme assays for novel USP17 subfamily members Figure 5
Deubiquitinating enzyme assays for novel USP17 subfamily members. In vitro deubiquitinating enzyme activity for USP17K, 
USP17L, USP17M, and USP17N. Immunoblotting analysis was performed with anti-β-gal antiserum. Coexpressed plasmids 
were pGEX-2TK (lane 1), pGEX-2TK-USP17K (lane 2), pGEX-2TK-USP17K (C89S) (lane 3), pGEX-2TK-USP17L (lane 4), 
pGEX-2TK-USP17L (C89S) (lane 5), pGEX-2TK-USP17M (lane 6), pGEX-2TK-USP17M (C89S) (lane 7), pGEX-2TK-USP17N 
(lane 8), and pGEX-2TK-USP17N (C89S) (lane 9). All of normal USP17 subfamily members cleaved the linkage between ubiqui-
tin and β-galactosidase.
Ub-˟-gal
˟-gal Blot: anti-˟-gal
Blot: anti-GST GST-USP
pGEX-2TK
pGEX-2TK-USP17K
pGEX-2TK-USP17K (C89S)
pGEX-2TK-USP17L
pGEX-2TK-USP17L (C89S)
pGEX-2TK-USP17M
pGEX-2TK-USP17M (C89S)
pGEX-2TK-USP17N
pGEX-2TK-USP17N( C89S)
1 23456 8 79BMC Genomics 2006, 7:292 http://www.biomedcentral.com/1471-2164/7/292
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ing the cell division [31]. Since USP17 subfamily proteins
except USP17N binds to hyaluronan and induces cell
death, it is possible that hyaluronan and/or RNA binding
domains of USP17 subfamily proteins may be involved in
the regulation of cell cycle or tumorigenesis. Another pos-
sibility is that hyaluronan may serve as a bridge between
the USP17 subfamily enzymes and their potential sub-
strates, which are intracellular hyaluronan-binding pro-
teins. Moreover, USP17 subfamily proteins are condensed
at the nucleoli like hyaluronan dose, suggesting that
USP17 subfamily proteins are involved in mRNA stability
or chromatin remodeling similar to functions of PAI-
RBP1 and Ki-1/57, which are hyaluronan/RNA binding
motif-containing proteins [29,30]. Due to the fact that in
vivo deubiquitinating enzyme assay for USP17 subfamily
members showed the extensive reduction of ubiquitina-
tion for cellular proteins (Fig. 6), it is possible that a
number of proteins including apoptosis-related proteins
can be regulated by USP17 subfamily members. Impor-
tant direction for future studies should include the isola-
tion and characterization of substrates for USP17. This
will help us to understand the cellular roles of USP17.
Conclusion
In this study, we report that four novel USP17 subfamily
members which encode a deubiquitinating enzyme have
been identified and that the overexpression of these pro-
teins leads to cell death. Our study demonstrates that
USP17 subfamily members, which regulate apoptosis and
cell death of cancerous cells, contain putative hyaluronan
and RNA binding motifs. Despite of a decade of research
since the discovery of DUB enzymes as an important mol-
ecule responsible for regulating protein degradation,
much remains to be defined regarding their cellular func-
tions. A better understanding of relation between USP17
subfamily proteins and cell viability will facilitate thera-
peutic strategies for regulation of cell proliferation.
Methods
Specimens and transfection
Chorionic villi samples used were described previously
[36]. Various human cancer cells (HeLa, HEC-1A, NCCIT,
and fibrosarcoma cells) were cultured in DMEM (Gibco
BRL, Rockville, MD, USA) supplemented with 10% fetal
bovine serum (Gibco BRL, Rockville, MD, USA). Transfec-
tion was performed with LipofectAMINE reagent (Gibco
BRL, Rockville, MD, USA) according to manufacturer's
instruction.
cDNA synthesis and cloning for USP17 subfamily members
TRIzol reagent (Gibco BRL, Rockville, MD, USA) was used
for total RNA isolation from obtained chorionic villi,
HeLa, HEC-1A, NCCIT, and fibrosarcoma cells. cDNA
synthesis from obtained total RNA was in accordance with
the protocol of SuperScript Preamplification system
(Gibco BRL, Rockville, MD, USA). The full-length cDNAs
were amplified by RT-PCR in human chorionic villi tis-
sues, HeLa, HEC-1A, NCCIT, and fibrosarcoma cells.
Primers (Forward: 5'-CGGGATCCATGGAGGACG-3',
Reverse: 5'-GGAATTCCACTGAGATCACT-3') used for iso-
lating putative DUB genes are made on the basis of pub-
lished sequences [GenBank: XM_252830]. Primers used
were synthesized commercially and gel-purified prior to
use (Bioneer, Daejeon, Korea). To express GST fusion pro-
teins, pGEX-2TK-USP17K, pGEX-2TK-USP17L, pGEX-
2TK-USP17M, and pGEX-2TK-USP17N  were cloned by
inserting each USP17 subfamily member into pGEX-2TK
vector (Amersham Life Science, Uppsala, Sweden). BLAST
programs on the web site established by the National
Center of Biological Information [37] were used for simi-
larity searches in the GenBank, and Pfam [27] program
was used for prediction of possible motifs and domains in
the protein sequences.
Site-directed mutagenesis of USP17 subfamily members
Missense mutation constructs for pGEX-2TK-USP17K
(C89S), pGEX-2TK-USP17L (C89S), pGEX-2TK-USP17M
(C89S), and pGEX-2TK-USP17N  (C89S) were derived
In vivo deubiquitinating enzyme assay for the novel USP17  subfamily member Figure 6
In vivo deubiquitinating enzyme assay for the novel USP17 
subfamily member. HA-tagged pMT123-ubiquitin was tran-
siently expressed in HEC-1A cells with or without pcDNA3-
myc-USP17L and pcDNA3-myc-USP17L (C89S). The expres-
sion levels of polyubiquitinated proteins were decreased in 
cells expressing pcDNA3-myc-USP17L, but not in cells 
expressing pcDNA3-myc-USP17L (C89S).
None
USP17L
USP17L+Ub
Ub
Blot: anti-myc
Blot: anti-HA
USP17L (C89S)+Ub
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from each wild type construct by PCR-based site-directed
mutagenesis, using a QuikChange™ Site-Directed Muta-
genesis kit (Stratagene, La Jolla, CA, USA) according to
manufacturers' instructions. The two primers; forward
primer (5'-GGGAAATACCCGCTACGTGAACGCTTC-3')
and reverse primer (5'-GAAGCGTTCACGTAGCGGG-
TATTTCC-3') were used for replacing cysteine with serine
at amino acid 89 of USP17 subfamily proteins. Primers
used were synthesized commercially and gel-purified
prior to use (Bioneer, Daejeon, Korea).
Northern blot analysis
As described previously [36], Northern blot analysis was
carried out to confirm the expression level of USP17 tran-
scripts using a human tissue blot purchased from Clon-
tech. The immobilized nucleic acids were hybridized with
radiolabeled DNA probes. Probes used for this study was
the 5' 500 bp and 3' 1 kb of USP17L. They were labeled by
random primers with [32P]dCTP (Amersham Biosciences,
Buckinghamshire, England). Hybridization was per-
formed in a bag containing 5 × SSC, 1 × Denhardt's solu-
Hyaluronan/RNA-binding assays Figure 7
Hyaluronan/RNA-binding assays. To confirm the interaction of USP17 subfamily proteins with either hyaluronan or RNA, CPC 
precipitation assay was performed. Cell lysate aliquots from HeLa cells transfected with myc-tagged USP17L or myc-tagged 
USP17N construct were incubated with hyaluronan or RNA and subjected to CPC precipitation. (A) Coprecipitated proteins 
were subjected to Western blot analysis with an antibody against the myc tag. CPC precipitation without the addition of CPC 
or myc-tagged USP17 construct was used as negative controls (lanes 1–3). Without the addition of CPC, the whole cell lysate 
from cells transfected with myc-tagged USP17L or myc-tagged USP17N was used as a positive control (lane 7). (B) For RNA 
binding assay, total RNA of HeLa cells instead of hyaluronan were added.
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The localization of USP17L and USP17N in HeLa cells Figure 8
The localization of USP17L and USP17N in HeLa cells. pEGFP-C1 vector (A) or pDsRed-C1 vector (B) transfected into HeLa 
cells was used as controls. In addition, GFP-tagged USP17L (C) or RFP-tagged USP17N (D) transfected into HeLa cells was 
used as controls. (E-G) HeLa cells co-transfected with GFP-tagged USP17L and RFP-tagged USP17N are shown with lower 
magnification (E-G) and with higher magnification (H-J). GFP-tagged USP17L proteins are highly condensed at the nucleoli in 
the nucleus (H: marked by arrows). RFP-tagged USP17N proteins are present both in the nucleus and cytoplasm (I: marked by 
arrows). GFP-tagged USP17L and RFP-tagged USP17N were combined in HeLa cells (G and J).
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tion, 100 µg/ml of denatured salmon sperm DNA, 0.1%
SDS and 50% formamide at 60°C and it was washed in
0.1 × SSC and 0.2% SDS, the membrane was exposed to
Kodak X-ray films with an intensifying screen for 24 hours
at -70°C.
Deubiquitinating enzyme assays
Deubiquitinating enzyme assays were previously
described [9]. For the in vitro deubiquitination assay,
pGEX-2TK-USP17K, pGEX-2TK-USP17K  (C89S), pGEX-
2TK-USP17L, pGEX-2TK-USP17L  (C89S), pGEX-2TK-
USP17M, pGEX-2TK-USP17M  (C89S), pGEX-2TK-
USP17N, and pGEX-2TK-USP17N (C89S) were co-trans-
formed into E. coli BL21 competent cells (Stratagene, La
Jolla, CA, USA) with pACYC184-Ub-β-gal. Plasmid-bear-
ing  E. coli BL21 cells were grown in LB medium and
induced with isopropyl-1-thio-β-D-galactopyranoside
(IPTG) for 4 hours at 37°C. Cells were harvested and were
lysed in cracking buffer (0.01 M phosphate [pH 7.4]. 8 M
Urea, 1% SDS, and 1% β-mercaptoethanol). These whole
cell lysates centrifuged for 10 min at 14,000 rpm and the
supernatant was loaded onto a 7.5% SDS-PAGE gel. The
immunoblotting was performed with a rabbit anti-β-gal
antiserum (ICN, Costa Mesa, CA, USA) or a rabbit anti-
GST antiserum (Upstate Biotechnology, Lake Placid, NY,
USA).
The effect of USP17 expression in HeLa cells Figure 9
The effect of USP17 expression in HeLa cells. Overexpression of USP17L-induced apoptosis of cervical cancer cells. Either 
USP17L (C89S) or USP17N did not induce apoptosis.
USP17L (C89S)
USP17L  Control (HeLa)
USP17N 
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The effect of USP17 expression on the ubiquitin-proteas-
ome system in vivo was analyzed by transfecting pcDNA3-
myc-USP17L or pcDNA3-myc-USP17L (C89S) along with
pMT123-HA-ubiquitin into HEC-1A cells. After 24 hours
of transfection, cells were harvested and lysed. 40 µg of
total proteins was loaded in each lane of a 10% SDS-PAGE
for immunoblotting analysis using an anti-HA antibody
(Roche Applied Science, Mannheim, Germany). Equal
loading was verified by immunoblotting against α-myc
(Santa Cruz Biotechnology, Santa Cruz, CA, USA).
Real-time PCR analysis and the Tet-on system
After the transfection of pcDNA3-myc-USP17L, the
expression of caspase 3 as a marker for apoptosis was ana-
lyzed by real-time PCR (Opticon2, MJ Research, Ramsey,
MN, USA). Product specificity was examined by melting
curve analysis and agarose gel electrophoresis after each
real-time PCR reaction. To normalize the expression data
of the genes, GAPDH was used (Forward primer: 5'-ACT-
GGTGCTGCCAAGGCTGT-3', Reverse primer: 5'-TCCAC-
CACCCTGTTGCTGTA-3'). Quantification was performed
using an internal cDNA standard curve. Fold changes of
caspase 3 expression in USP17L-overexpressed cells were
calculated relative to the levels in control cells.
For the long-term (3 weeks) observation and FACS analy-
sis, USP17L was expressed in HeLa cells using the Tet-on
system (Gibco BRL, Rockville, MD, USA) by manufac-
turer's instruction. Expression of USP17L was confirmed
by real-time PCR analysis.
FACS analysis
For apoptosis analysis, HeLa-Tet-on cells expressing
USP17L were harvested in PBS and resuspended 100 µl of
binding buffer (10 mM Hepes/NaOH, pH 7.4, 140 mM
NaCl, 2.5 mM CaCl2). 5 µl annexin V-FITC (BD Bio-
sciences, Bedford, MA, USA) and 10 µl propidium iodide
(PI, 50 µg/ml, BD Biosciences, Bedford, MA, USA) were
added and incubated 15 minutes in the dark. Finally 400
µl of binding buffer was added and analyzed by FACSVan-
tage™ SE system (BD Biosciences, Bedford, MA, USA).
Cells in stage of apoptosis were differentiated depending
on the location in quadrant (annexin V +, PI -; early stage)
and (annexin V +, PI +; late stage) [34].
Localization study
USP17L and USP17N were subcloned into pEGFP-C1 and
pDsRed-C1 (Clontech, Palo Alto, CA, USA), respectively,
and transfected into HeLa cells using ExGen500 (Fermen-
The effect of USP17 expression in HeLa cells Figure 10
The effect of USP17 expression in HeLa cells. Relative amounts of caspase 3 produced by real-time PCR. The amount of cas-
pase 3 DNA in the control group was calibrated as 100 and relative amounts of caspase 3 DNA in cells transfected with either 
USP17L, USP17L (C89S) or USP17N were determined.
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tas, Hanover, MD, USA). After 48 hours, the localization
of GFP-tagged USP17L  and RFP-tagged USP17N  was
observed using a confocal microscopy (Radiance 2100
2Q, Bio-Rad, Hercules, CA, USA). In order to observe the
morphology of nuclei for HeLa cells, DAPI staining was
performed. After the fixation, 5 µl of DAPI staining solu-
tion (Roche Applied Science, Mannheim, Germany) was
added in wells containing HeLa cells, which express either
GFP-tagged USP17L or RFP-tagged USP17N. Stained cells
were observed using Nikon Eclipse E600 microscopy.
Hyaluronan- and RNA-binding assays
These assays were previously described [29]. 9 µg of
pcDNA3-myc-USP17L  or pcDNA3-myc-USP17N  was
transiently transfected into 1 × 106 HeLa cells in 100Φ
dish by ExGen500 transfection reagent (Fermentas, Hano-
ver, MD, USA). The supernatant from lysates was divided
into 100 µl aliquots in Eppendorf tube and incubated at
room temperature with 50 µg of hyaluronan (H5388,
Sigma, St. Louis, MO, USA). For RNA binding assay, this
procedure was repeated with using total RNA of HeLa cells
instead of hyaluronan.
Abbreviations
CPC, cetylpyridinium chloride; DUB, deubiquitinating
enzyme; E1, ubiquitin-activating enzyme; E2, ubiquitin-
conjugating enzyme; E3, ubiquitin ligase; ECL, enhanced
chemiluminescence; GST, glutathione S-transferase; HA,
hemagglutinin; IHABPS, intracellular hyaluronan binding
proteins; IP, immunoprecipitation; JAMM, Jab1/Pab1/
MPN-domain-containing metallo-enzyme; OTU, otu-
domain ubiquitin aldehyde-binding protein; PCR,
polymerase chain reaction; PI, propidium iodide;
RHAMM, receptor form hyaluronan-mediated motility;
SDS-PAGE; sodium dodecyl sulfate-polyacrylamide gel
electrophoresis; Ub, ubiquitin; UBP, ubiquitin specific
processing protease; UCH, ubiquitin C-terminal hydro-
lase.
(A) FACS analysis Figure 11
(A) FACS analysis. Cells expressing USP17L, USP17L (C89S), or USP17N were harvested 1 week apart for 3 weeks, fixed with 
ethanol, and stained with annexin V and PI. (B) The graph shows the ratio of cells in early (annexin V +, PI -) and late (annexin 
V +, PI +) stage apoptosis. The ratio of HeLa cells was calibrated as 100%.
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